MEDTOX Scientific Inc. (MTOX) Reports In-Line Q4 EPS
- Apple (AAPL) Tops Q1 EPS by 46c, Sales Beat
- Unusual 11 Mid-Day Movers 1/28: (ABMD) (PSTI) (FSL) Higher; (NBG) (BBG) (SALT) Lower
- FXCM, Inc. (FXCM) Will Forgive 90% of Clients that Incurred Negative Balances on Swiss Franc Volatility
- TE Connectivity (TEL) Will Sell BNS Unit to CommScope (COMM) in $3B Deal
- U.S. Steel (X) Tops Q4 EPS Views; Offers FY15 Outlook
MEDTOX Scientific Inc. (NASDAQ: MTOX) reported Q4 EPS of $0.09, in-line with the analyst estimate of $0.09. Revenue for the quarter came in at $25 million versus the consensus estimate of $24.49 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boeing (BA) Posts Q4 Core EPS of $2.31; Guides FY15 EPS Below Expectations
- Mastech Holdings (MHH) Reports Q4 EPS of $0.18
- Doral Financial (DRL) Reports Modification to FHLB Facility; FDIC Issues Prompt Corrective Action Directive
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!